Researchers at University of Tsukuba have developed a cellulose-based composite sheet that integrates paper pulp with starch, ...

On Jan. 15, 2026, investors took note of Anktiva's explosive sales ramp, its geographic expansion potential, and a possible new indication.

In July 2025, a class 2 resubmission of tab-cel’s BLA was initiated by Atara Biotherapeutics, developer and sponsor of ...

Among treatment-naive adults with advanced HIV disease, integrase inhibitors are a preferred first-line therapy over protease inhibitors.

Positioned to increase depth of Vafseo prescribing entering 2026 with access to approximately 275,000 patients First patient ...

As he approached Renee Good’s vehicle on a Minneapolis street on Wednesday, Immigration and Customs Enforcement agent Jonathan Ross held up his phone camera and recorded video. Less than a minute ...

Red blood cells are essential for oxygen transport and immune function in the human body. When these cells become abnormally shaped, they can indicate serious health conditions, including diabetes, ...

Bristol Myers Squibb BMY recently obtained FDA approval for the label expansion of Breyanzi (lisocabtagene maraleucel) for the treatment of adult patients with relapsed or refractory (R/R) marginal ...

MUMBAI, India and PRINCETON, N.J., Nov. 25, 2025 /PRNewswire/ -- Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE ...

Bristol Myers Squibb BMY obtained the European Commission’s (“EC”) approval for a label expansion of Breyanzi (lisocabtagene maraleucel; liso-cel), a CD19-directed chimeric antigen receptor (CAR) T ...